-

ADDING MULTIMEDIA KARL STORZ Announces FDA Clearance for ENDOFLATOR + Insufflator and Smoke Evacuation System

Single unit provides insufflation, smoke evacuation, and desufflation, with options for heated and humidified gas

EL SEGUNDO, Calif.--(BUSINESS WIRE)--KARL STORZ, a global leader in minimally invasive surgical technology, is proud to announce it has received U.S. Food and Drug Administration (FDA) clearance for the ENDOFLATOR™ +.

The ENDOFLATOR + insufflator represents a significant leap forward, combining high flowrates with integrated smoke removal.

Share

ENDOFLATOR + is the next-generation insufflator with integrated surgical smoke evacuation system designed to meet the evolving needs of modern operating rooms.

Using carbon dioxide gas, an insufflator establishes and maintains a stable working cavity within the body during laparoscopic and robotic procedures, providing surgeons with the necessary space to operate. When paired with smoke evacuation, the insufflator is designed to preserve image clarity by removing surgical smoke and particulates, improving visibility and allowing for enhanced surgical precision.

The ENDOFLATOR + represents a significant leap forward, offering high flowrates and an ULPA filter that helps maintain a smoke-free image, improving visibility and maneuverability while reducing harmful surgical smoke. Specific features include:

  • CO₂ insufflation up to 50 L/min
  • Integrated smoke evacuation in HF and continuous modes
  • Four procedural modes: high-flow, pediatric, taTME, and EVH
  • Heated and humidified gas delivery with proprietary tubing sets
  • RFID-enabled tubing for simplicity and safety

The system is engineered to support procedures across various specialties—general surgery, cardiovascular surgery, colorectal surgery, gynecology, pediatric surgery*, proctology, and urology—in both conventional laparoscopic and robotic settings.

“This launch marks a major milestone for KARL STORZ and the healthcare providers we serve,” said Fernando Morales, Vice President, Surgical & OR Integration. “The ENDOFLATOR + not only meets high standards of safety and performance but also aligns with new surgical smoke evacuation mandates across multiple states.”

The ENDOFLATOR + and its five proprietary tubing sets are now available for order. Customers are encouraged to contact their KARL STORZ representative for demos, pricing, and promotional offers.

*cleared for patients aged 2 and up

About KARL STORZ

KARL STORZ is an innovative leader in endoscopic technology and surgical imaging solutions across virtually all surgical specialties. Its integrated OR solutions, including advancements in digital surgery, enhance collaboration to improve clinical efficiency and outcomes inside the hospital and across other sites of care. With subsidiaries around the world, KARL STORZ is a family-owned company based in Germany that designs, engineers, manufactures, and markets all its products with an emphasis on visionary design, precision craftsmanship, and clinical effectiveness. For more information, visit www.karlstorz.com.

Contacts

Media contact:
Susan Mancia
Marketing Communications
KARL STORZ United States
657-385-5285

KARL STORZ


Release Versions

Contacts

Media contact:
Susan Mancia
Marketing Communications
KARL STORZ United States
657-385-5285

Social Media Profiles
More News From KARL STORZ

KARL STORZ Unifies Canada, US, and Veterinary Organizations to Form North America Region Led by Sonal Matai

EL SEGUNDO, Calif.--(BUSINESS WIRE)--KARL STORZ, a family-owned medical technology company headquartered in Tuttlingen, Germany, today announced the creation of a North America region that unifies its US, Canada, and Veterinary businesses under the leadership of Sonal Matai. Matai joined KARL STORZ in 2022 and was appointed to lead KARL STORZ United States in early 2024. As President of North America, Matai will now oversee key functions such as commercial operations, research and development,...

AventaMed, a KARL STORZ Company, Receives Expanded Indication for Solo+ Tympanostomy Tube Device (TTD)

EL SEGUNDO, Calif.--(BUSINESS WIRE)--KARL STORZ United States is proud to announce that the US Food and Drug Administration (FDA) has cleared an expanded indication for the AventaMed Solo+™ Tympanostomy Tube Device (TTD), allowing its use in pediatric patients aged 6 months and older. This expanded clearance builds on the previous 510(k) clearance, which was indicated for patients 6 to 24 months old. The Solo+ device represents a significant advancement in pediatric ENT care. It is intended to...

KARL STORZ Introduces the Slimline C-MAC S Single-Use Video Laryngoscope

EL SEGUNDO, Calif.--(BUSINESS WIRE)--KARL STORZ announces the worldwide launch of the Slimline C-MAC® S single-use video laryngoscope for airway management. Built to the same high-quality standards as all KARL STORZ products, the Slimline C-MAC S blade delivers clear visibility for a confident intubation, even in the most challenging cases. Designed for optimal performance in airway management Medical professionals use a video laryngoscope to help insert a breathing tube into a patient's airway...
Back to Newsroom